Clinical Trial

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the treatment of patients with locally advanced rectal cancer for complete response to neoadjuvant chemotherapy without the use of radiation and surgery.
Trial Details
NCT Number NCT03781323
Lead Sponsor University of Rochester
Conditions Advanced Rectal Cancer
Enrollment 12 participants
Start Date 2019-05-03
Primary Completion 2022-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04